Stroke and mortality in patients with incident heart failure: The Diet, Cancer and Health (DCH) cohort study

BMJ Open

Volumn 2, Issue 4, 2012, Pages

  Lip, Gregory Y H ^a,b   Rasmussen, Lars Hvilsted ^b,c   Skjøth, Flemming ^b,c   Overvad, Kim ^c,d   Larsen, Torben Bjerregaard ^b,c  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b AALBORG UNIVERSITY   (Denmark)

^c AALBORG UNIVERSITY HOSPITAL   (Denmark)

^d AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVITAMIN K;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIAC PATIENT; CLINICAL PRACTICE; COHORT ANALYSIS; CONTROLLED STUDY; DEATH; DENMARK; FEMALE; HAZARD RATIO; HEART FAILURE; HIGH RISK POPULATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PATIENT IDENTIFICATION; PROSPECTIVE STUDY; RISK; STROKE; THROMBOEMBOLISM; TRANSIENT ISCHEMIC ATTACK;

EID: 84864201154     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2012-000975     Document Type: Article

References (27)

1. Bui AL, Horwich TB, Fonarow GC. Epidemiology and risk profile of heart failure. Nat Rev Cardiol 2011;8:30-41.
2. Bettari L, Fiuzat M, Becker R, et al. Thromboembolism and antithrombotic therapy in patients with heart failure in sinus rhythm: current status and future directions. Circ Heart Fail 2011;4:361-8.
3. Alberts VP, Bos MJ, Koudstaal PJ, et al. Heart failure and the risk of stroke: the Rotterdam Study. Eur J Epidemiol 2010;25:807-12.
4. Uretsky BF, Thygesen K, Armstrong PW, et al. Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial. Circulation 2000;102:611-16. (Pubitemid 30640659)
5. Lip GYH, Chung I. Anticoagulation for heart failure in sinus rhythm. Cochrane Database Syst Rev 2001;(4):CD003336.
6. Lip GYH, Chung I. Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm. Cochrane Database Syst Rev 2001;(4):CD003333.
7. Massie BM, Collins JF, Ammon SE, et al WATCH Trial Investigators. Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial. Circulation 2009;119:1616-24.
8. Cleland JG, Ghosh J, Freemantle N, et al. Clinical trials update and cumulative meta-analyses from the American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-Lipids and cardiac resynchronisation therapy in heart failure. Eur J Heart Fail 2004;6:501-8. (Pubitemid 38746595)
9. Cleland JG, Findlay I, Jafri S, et al. The Warfarin/Aspirin Study in Heart failure (WASH): a randomised trial comparing antithrombotic strategies for patients with heart failure. Am Heart J 2004;148:157-64. (Pubitemid 38900496)
10. Tjonneland A, Olsen A, Boll K, et al. Study design, exposure variables, and socioeconomic determinants of participation in diet, cancer and health: a population-based prospective cohort study of 57,053 men and women in Denmark. Scand J Public Health 2007;35:432-41 (Pubitemid 47386794)
11. Lynge E, Sandegaard J, Rebolj M, et al. The Danish National Patient Register. Scand J Public Health 2011;39:30-3.
12. Kildemoes HW, Sørensen HT, Hallas J. The Danish National Prescription Registry. Scand J Public Health 2011;39:38-41.
13. Kirchhof P, Auricchio A, Bax J, et al. Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German atrial fibrillation competence NETwork and the European heart rhythm association. Europace 2007;9:1006-23. (Pubitemid 351773289)
14. Royston P, Altman DG. Regression using fractional polynomials of continuous covariates: parsimonious parametric modelling. Journal of the Royal Statistical Society 1994;43:429-67.
15. Heagerty PJ, Lumley T, Pepe MS. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 2000;56:337-44. (Pubitemid 30422619)
16. Drazner MH. The progression of hypertensive heart disease. Circulation 2011;123:327-34.
17. Szummer KE, Solomon SD, Velazquez EJ, et al VALIANT Registry. Heart failure on admission and the risk of stroke following acute myocardial infarction: the VALIANT registry. Eur Heart J 2005;26:2114-19. (Pubitemid 41407993)
18. Wolf PA, Kannel WB, McNamara PM. Occult impaired cardiac function, congestive heart failure, and risk of thrombotic stroke: the Framingham Study. Neurology 1970;20:373.
19. Witt BJ, Brown RD Jr, Jacobsen SJ, et al. Ischemic stroke after heart failure: a community-based study. Am Heart J 2006;152:102-9. (Pubitemid 43974732)
20. Homma S, Thompson JL, Pullicino PM, et al; the WARCEF Investigators. Warfarin and Aspirin in Patients with Heart Failure and Sinus Rhythm. N Engl J Med 2012. [Epub ahead of print] doi:10.1056/NEJMoa1202299
21. Hughes S. MAGELLAN: Rivaroxaban Prevents VTE in Medical Patients, But Bleeding An Issue. theheart.org. [clinical conditions >thrombosis > thrombosis risk]. 2011. http://www.theheart.org/article/1207331.do (accessed 9 Oct 2011).
22. Deedwania PC, Lardizabal JA. Atrial fibrillation in heart failure: a comprehensive review. Am J Med 2010;123:198-204.
23. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007;146:857-67. (Pubitemid 351650486)
24. Lip GY, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation. Chest 2010;137:263-72.
25. Hickey KT, Reiffel J, Sciacca RR, et al. The utility of ambulatory electrocardiographic monitoring for detecting silent arrhythmias and clarifying symptom mechanism in an urban elderly population with heart failure and hypertension: clinical implications. J Atr Fibrillation 2010;1:663-74.
26. Siachos T, Vanbakel A, Feldman DS, et al. Silent strokes in patients with heart failure. J Card Fail 2005;11:485-9. (Pubitemid 41399886)
27. Badheka AO, Rathod A, Kizilbash MA, et al. Comparison of mortality and morbidity in patients with atrial fibrillation and heart failure with preserved versus decreased left ventricular ejection fraction. Am J Cardiol 2011;108:1283-8.